22 February 2024 | Thursday | News
Image Source | Public Domain
LabVantage Solutions, Inc., the premier provider of laboratory informatics solutions and services, has launched an integrated, digitally native ecosystem tailored to support R&D laboratory processes efficiently. This innovative ecosystem seamlessly combines LabVantage's semantic search (AILANI), advanced analytics, and LIMS solutions, empowering R&D labs to enhance efficiency, productivity, decision-making, collaboration, and time-to-market while reducing operational costs. LabVantage will unveil its comprehensive LIMS solutions and integrated ecosystem at Pittcon 2024 (Booth #2133), taking place from February 24-28 in San Diego, California.
Digitizing R&D laboratory processes with advanced technologies such as semantic search, analytics, and LIMS signifies a significant advancement in scientific efficiency and innovation. Leveraging semantic search capabilities enables the contextualization and searchability of vast datasets and documents through a semantic core and knowledge graph. This technology not only streamlines information retrieval and drastically reduces experimental repetitions but also enhances decision-making by offering more relevant and precise data insights. LabVantage customers implementing the semantic search tool, AILANI, have reported a notable 30% reduction in repeated experiments.
Integration of AI and Business Intelligence into a unified analytics platform, alongside LIMS, accelerates analysis and reporting processes. LabVantage Analytics facilitates the analysis of both structured and unstructured data from diverse sources, consolidating data processing, storage, analysis, and visualization into a single platform. Its user-friendly self-service features, including customizable dashboards and instant access to LIMS data reports, further enhance user experience.
Alan Marcus, Chief Growth Officer at LabVantage Solutions, emphasized, “By incorporating advanced technologies like semantic search, AI, and analytics into our LIMS solutions, we're not only enhancing data precision and reducing experimental repetition but also driving significant improvements in collaboration and experiment design. Together, these tools will be instrumental in enabling customers to design better experiments while drastically reducing the total number of experimental runs. Our goal is to hand back more time to customers for scientific exploration. In fact, we believe these digitally native solutions will expand our ability to serve clients in all supported industries throughout their entire product lifecycle. Your data can now be unified, housed, searched, and analyzed within a single platform from concept to market.”
The implementation of LIMS automates and manages laboratory workflows, significantly enhancing efficiency and consistency in experiment execution. Integrated with search and analytics tools, LabVantage LIMS ensures a seamless flow of information, further elevating laboratory operations, decision-making, and collaboration. Industry statistics highlight the transformative impact of digitization and automation, with laboratories reporting up to a 30-40% increase in productivity.
LabVantage's merger with Biomax Informatics has further enriched its analytics and LIMS solutions by integrating AILANI, an advanced semantic search tool. AILANI synergizes semantic modeling, ontologies, linguistics, and AI algorithms to revolutionize query-based research, enabling researchers to swiftly discover valuable insights and hidden patterns across various data sources. Recognized in the Gartner® Hype Cycle™ for Life Science Discovery Research 2023 as a Sample Vendor for 'Semantic Knowledge Graph Tools' and 'Analytics Platforms for Research Informatics', LabVantage Biomax underscores its commitment to transforming life science research and analytics.
Similarly, LabVantage was acknowledged as a top growth and innovation leader in 2023 by Frost & Sullivan in their inaugural global life sciences LIMS report and radar, highlighting LabVantage's pivotal role in driving innovation and transformation in life science research and analytics
© 2024 Biopharma Boardroom. All Rights Reserved.